Did you know?

Larry N Feinberg, the manager of Oracle Associates, has opened a position in BIOLASE Inc (NASDAQ: BIOL).In a recent filing with the Securities and Exchange Commission, Mr. Feinberg disclosed ...Nov 18, 2023 · BIOLASE Stock Performance. Shares of BIOL stock opened at $1.25 on Tuesday. The company has a quick ratio of 0.71, a current ratio of 1.40 and a debt-to-equity ratio of 34.06. The firm has a 50 day moving average price of $1.78 and a two-hundred day moving average price of $11.22. BIOLASE has a 12-month low of $1.07 and a 12-month high of $175.99. BIOL Biolase Inc stock NASDAQ ... Shares Out. ... biolase, inc. is a medical device company that develops, manufactures, markets, and sells laser systems in ...NEW YORK, NY / ACCESSWIRE / March 25, 2021 / BIOLASE, Inc. (NASDAQ:BIOL) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 25, 2021 at 4:30 ...FOOTHILL RANCH, Calif., Aug. 31, 2021 /PRNewswire/ -- Today BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced a clinical advisory partnership with Dr. L. Stephen Buchanan ...NASDAQNYSEIBEX35LSEDAXCRYPTO. Buscar. NASDAQ:BIOL. BIOLASE Inc. Sector. Health. Industry. Medical supplies and equipment. 1,65 $ Last price. -0,03 $ VARIATION.FOOTHILL RANCH, Calif., Feb. 23, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced that the Board of Directors has appointed John R. Beaver, the ...BIOL stock is up 44% year-to-date, but it’s literally a penny stock trading at about 70 cents a share, with a $101 million market cap. The stock has a B-rating in my Portfolio Grader . Best ...BIOLASE (NASDAQ:BIOL) plummets 47.31% premarket on pricing of an underwritten public offering consisting of 16,453,569 shares of its common stock and pre-funded warrants to purchase 11,403,571 ...BIOL Sales Forecast. Next quarter’s sales forecast for BIOL is $14.75M with a range of $13.35M to $16.70M. The previous quarter’s sales results were $10.92M. BIOL beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 46.34% of the time in the same period.Find the latest on short interest for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com.Nike, Inc. has no single specific owner. According to Nasdaq, the company is a publicly traded one, with its shares listed on the New York Stock Exchange under the symbol NKE. As of May, 2014, 83.29 percent of Nike’s shares were owned by in...The latest price target for . Biolase (NASDAQ: BIOL) was reported by Lake Street on May 31, 2023.The analyst firm set a price target for $0.40 expecting BIOL to fall to within 12 months (a ...26 Jul, 2023, 16:30 ET. COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON JULY 28, 2023. LAKE FOREST, Calif., July 26, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ) ("BIOLASE" or the ...LOS ANGELES, March 27, 2019 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, TeamSmile, the nation's premier advocacy group that supports life-changing dental care ...FOOTHILL RANCH, Calif., May 3, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today sent the following letter to stockholders regarding the upcoming 2021 ...Dec 1, 2023 · Short selling BIOL is an investing strategy that aims to generate trading profit from BIOLASE as its price is falling. BIOL shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. BIOLASE, Inc. (NASDAQ:NASDAQ:BIOL) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ETCompany ParticipantsTodd Kehrli - Investor Relations, EVC...Nov 14, 2022 · LAKE FOREST, Calif., Nov. 14, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to participate in the 11 th Annual ... BIOL Biolase Inc Form 8-K - Current report BIOLASE, INC May 12, 2023 · BIOLASE, Inc. (NASDAQ:NASDAQ:BIOL) Q1 2023 Earning /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for its third quarter ended September... The answer lies in Nasdaq rules that give companies generous gra IRVINE, Calif., Feb. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has entered into an underwriting agreement with Maxim Group ... BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "

BIOL / Biolase Inc (NASDAQ) - Forecast, Price Target, Estimates, Predictions.Biolase Inc (NASDAQ:BIOL) is not the least popular stock in this group but hedge fund interest is still below average. Our overall hedge fund sentiment score for BIOL is 19.8. Stocks with higher ...Nov 29, 2023 · BIOLASE (NASDAQ:BIOL) and ReShape Lifesciences (NASDAQ:RSLS) are both small-cap medical companies, but which is the superior investment?We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, community ranking, analyst recommendations and profitability. LAKE FOREST, Calif., July 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2022 financial and operating results on Thursday, August 11, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day …

BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that it held a special meeting of its stockholders on July 20, 2023 where the Company's ...…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Nike, Inc. has no single specific owner. According to Nas. Possible cause: Analyst Recommendations on BIOLASE, Inc. Biolase Files Registration Statement for Un.